|
|
Volumn 342, Issue 7804, 2011, Pages
|
|
Guidelines: Recognition and initial management of ovarian cancer: Summary of NICE guidance
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CA 125 ANTIGEN;
CARBOPLATIN;
TUMOR MARKER;
MEMBRANE PROTEIN;
MUC16 PROTEIN, HUMAN;
ABDOMINAL HYSTERECTOMY;
ANTIGEN DETECTION;
CANCER ADJUVANT THERAPY;
CANCER STAGING;
CLINICAL FEATURE;
CYTOLOGY;
DRUG ADMINISTRATION ROUTE;
HISTOLOGY;
HUMAN;
LYMPHADENECTOMY;
MULTIPLE CYCLE TREATMENT;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OVARY CANCER;
PATIENT ASSESSMENT;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SHORT SURVEY;
TREATMENT INDICATION;
TUMOR BIOPSY;
ULTRASOUND;
ADJUVANT CHEMOTHERAPY;
ARTICLE;
DIAGNOSTIC IMAGING;
EARLY DIAGNOSIS;
FEMALE;
LYMPH NODE METASTASIS;
METABOLISM;
OVARY TUMOR;
RISK ASSESSMENT;
CA-125 ANTIGEN;
CHEMOTHERAPY, ADJUVANT;
DIAGNOSTIC IMAGING;
EARLY DETECTION OF CANCER;
FEMALE;
HUMANS;
LYMPH NODE EXCISION;
LYMPHATIC METASTASIS;
MEMBRANE PROTEINS;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
PRACTICE GUIDELINES AS TOPIC;
RISK ASSESSMENT;
|
|
EID: 79960096607
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.d2073 Document Type: Short Survey |
|
Times cited : (25)
|
|
References (9)
|
